SUBSCRIPTION AGREEMENTSubscription Agreement • July 1st, 2008 • MedaSorb Technologies CORP • Surgical & medical instruments & apparatus • New York
Contract Type FiledJuly 1st, 2008 Company Industry JurisdictionTHIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of June __, 2008, by and among MedaSorb Technologies Corporation, a Nevada corporation (the “Company”), and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subscribers”).
EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2008 • MedaSorb Technologies CORP • Surgical & medical instruments & apparatus • New Jersey
Contract Type FiledJuly 1st, 2008 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into this 18th day of June 2008, by and between MedaSorb Technologies Corporation, (the “Company”), and David Lamadrid (“Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2008 • MedaSorb Technologies CORP • Surgical & medical instruments & apparatus • New Jersey
Contract Type FiledJuly 1st, 2008 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this "Agreement") is entered into this 18th day of June, 2008, by and between MedaSorb Technologies Corporation, (the "Company"), and Al Kraus ("Employee"). This Employment agreement is contingent upon closing a $4 million Series B financing led by NJTC Venture Fund (“NJTC”) in June 2008 and will replace the employment agreement executed between Employee and the Company dated December 31, 2007. If this condition is not met, there will be no change in the Employee’s current employment agreement.
AGREEMENT AND CONSENTAgreement and Consent • July 1st, 2008 • MedaSorb Technologies CORP • Surgical & medical instruments & apparatus • New York
Contract Type FiledJuly 1st, 2008 Company Industry JurisdictionThis AGREEMENT AND CONSENT (this “Agreement”), dated as of June 25, 2008, is made by and among MedaSorb Technologies Corporation, a Nevada corporation (the “Company”), and the holders of the Series A 10% Cumulative Convertible Preferred Stock, par value $0.001 per share (the “Series A Preferred Stock”) of the Company signatory hereto (each a “Holder” and collectively the “Holders”).